Mechanism of Action of Mannitol as an Osmotic Diuretic
Mannitol works primarily by creating an osmotic gradient across the blood-brain barrier and renal tubules, drawing water from tissues into the intravascular space while simultaneously inhibiting tubular reabsorption of water and electrolytes in the kidneys.
Primary Mechanisms
Osmotic Effects in the Brain
Mannitol functions as an intravascular osmotic agent that draws fluid from both edematous and non-edematous brain tissue by increasing the osmotic pressure of plasma and extracellular space 1, 2. The drug has a reflection coefficient of 0.9 at the blood-brain barrier, meaning it remains largely confined to the extracellular space and creates a sustained osmotic gradient 3, 2. This causes transient increase in extracellular osmolarity, inducing water displacement from the intracellular to the extracellular and vascular compartments 4.
The maximum ICP-lowering effect occurs within 10-15 minutes of administration, with effects lasting 2-4 hours 4.
Renal Mechanisms
In the kidneys, mannitol is freely filtered by the glomeruli with less than 10% tubular reabsorption 2. It hinders tubular reabsorption of water and enhances excretion of sodium and chloride by elevating the osmolarity of the glomerular filtrate 2. The mechanism involves reducing the osmotic driving force for paracellular reabsorption of water and NaCl across tight junctions in the proximal tubules 5, 6.
Secondary Hemodynamic Effects
Cardiovascular Actions
Mannitol increases cardiac preload and cerebral perfusion pressure (CPP), thereby decreasing ICP through cerebral autoregulation 1. It also decreases blood viscosity, which results in reflex vasoconstriction and decreased cerebrovascular volume 1. The drug can increase cardiac output through volume expansion (increased preload) and reduced systemic vascular resistance (decreased afterload) 3.
Cerebral Blood Flow Modulation
Mannitol increases cerebral blood flow and may improve cerebral oxygenation 4. Studies demonstrate that mannitol was the only ICP-lowering therapy (compared to external ventricular drainage and hyperventilation) associated with improved cerebral oxygenation 4.
Distribution and Pharmacokinetics
Mannitol distributes largely to the extracellular space within 20-40 minutes after intravenous administration, with a volume of distribution of approximately 17 L in adults 2. The elimination half-life ranges from 0.5 to 2.5 hours in patients with normal renal function, with approximately 80% of a dose appearing in urine within 3 hours 2.
Important Clinical Caveats
- Mannitol induces osmotic diuresis requiring volume compensation, which distinguishes it from hypertonic saline that has minimal diuretic effect 4
- The drug can cause hypovolemia and hypotension if fluid replacement is inadequate 1, 7
- Target serum osmolality is typically 300-320 mOsm/kg, though definitive thresholds lack strong evidence 1
- Only a small amount of mannitol is metabolized; it acts primarily as an intact osmotic molecule 2